Literature DB >> 12524301

19 A solution structure of the filarial nematode immunomodulatory protein, ES-62.

Claire J Ackerman1, Margaret M Harnett, William Harnett, Sharon M Kelly, Dmitri I Svergun, Olwyn Byron.   

Abstract

ES-62, a protein secreted by filarial nematodes, parasites of vertebrates including humans, has an unusual posttranslational covalent addition of phosphorylcholine to an N-type glycan. Studies on ES-62 from the rodent parasite Acanthocheilonema viteae ascribe it a dominant role in ensuring parasite survival by modulating the host immune system. Understanding this immunomodulation at the molecular level awaits full elucidation but distinct components of ES-62 may participate: the protein contributes aminopeptidase-like activity whereas the phosphorylcholine is thought to act as a signal transducer. We have used biophysical and bioinformatics-based structure prediction methods to define a low-resolution model of ES-62. Sedimentation equilibrium showed that ES-62 is a tightly bound tetramer. The sedimentation coefficient is consistent with this oligomer and the overall molecular shape revealed by small angle x-ray scattering. A 19 A model for ES-62 was restored from the small-angle x-ray scattering data using the program DAMMIN which uses simulated annealing to find a configuration of densely packed scattering elements consistent with the experimental scattering curve. Analysis of the primary sequence with the position-specific iterated basic local alignment search tool, PSI-BLAST, identified six closely homologous proteins, five of which are peptidases, consistent with observed aminopeptidase activity in ES-62. Differences between the secondary structure content of ES-62 predicted using the consensus output from the secondary structure prediction server JPRED and measured using circular dichroism are discussed in relation to multimeric glycosylated proteins. This study represents the first attempt to understand the multifunctional properties of this important parasite-derived molecule by studying its structure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12524301      PMCID: PMC1302629          DOI: 10.1016/S0006-3495(03)74868-1

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  44 in total

1.  Molecular cloning and demonstration of an aminopeptidase activity in a filarial nematode glycoprotein.

Authors:  W Harnett; K M Houston; R Tate; T Garate; H Apfel; R Adam; S M Haslam; M Panico; T Paxton; A Dell; H Morris; H Brzeski
Journal:  Mol Biochem Parasitol       Date:  1999-10-25       Impact factor: 1.759

2.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

3.  Low resolution structure of the sigma54 transcription factor revealed by X-ray solution scattering.

Authors:  D I Svergun; M Malfois; M H Koch; S R Wigneshweraraj; M Buck
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

4.  Reconstruction of protein form with X-ray solution scattering and a genetic algorithm.

Authors:  P Chacón; J F Díaz; F Morán; J M Andreu
Journal:  J Mol Biol       Date:  2000-06-23       Impact factor: 5.469

5.  A prediction of the amino acids and structures involved in DNA recognition by type I DNA restriction and modification enzymes.

Authors:  S S Sturrock; D T Dryden
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

Review 6.  Aminopeptidases: towards a mechanism of action.

Authors:  A Taylor
Journal:  Trends Biochem Sci       Date:  1993-05       Impact factor: 13.807

7.  The structure of the Aeromonas proteolytica aminopeptidase complexed with a hydroxamate inhibitor. Involvement in catalysis of Glu151 and two zinc ions of the co-catalytic unit.

Authors:  B Chevrier; H D'Orchymont; C Schalk; C Tarnus; D Moras
Journal:  Eur J Biochem       Date:  1996-04-15

8.  Studies on immune responses to parasite antigens in mice. IV. Inhibition of an anti-DNP antibody response with the antigen, DNP-Ficoll containing phosphorylcholine.

Authors:  G F Mitchell; H M Lewers
Journal:  Int Arch Allergy Appl Immunol       Date:  1976

9.  Crystal structure of Aeromonas proteolytica aminopeptidase: a prototypical member of the co-catalytic zinc enzyme family.

Authors:  B Chevrier; C Schalk; H D'Orchymont; J M Rondeau; D Moras; C Tarnus
Journal:  Structure       Date:  1994-04-15       Impact factor: 5.006

10.  Phosphorylcholine: friend or foe of the immune system?

Authors:  W Harnett; M M Harnett
Journal:  Immunol Today       Date:  1999-03
View more
  5 in total

1.  Low-resolution reconstruction of a synthetic DNA holliday junction.

Authors:  Marcelo Nöllmann; W Marshall Stark; Olwyn Byron
Journal:  Biophys J       Date:  2004-05       Impact factor: 4.033

2.  The solution structure and oligomerization behavior of two bacterial toxins: pneumolysin and perfringolysin O.

Authors:  Alexandra S Solovyova; Marcelo Nöllmann; Timothy J Mitchell; Olwyn Byron
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

Review 3.  Signalling mechanisms underlying subversion of the immune response by the filarial nematode secreted product ES-62.

Authors:  Helen S Goodridge; Gillian Stepek; William Harnett; Margaret M Harnett
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

4.  Solution structure of the major (Spy0128) and minor (Spy0125 and Spy0130) pili subunits from Streptococcus pyogenes.

Authors:  Alexandra S Solovyova; Jonathan A Pointon; Paul R Race; Wendy D Smith; Michael A Kehoe; Mark J Banfield
Journal:  Eur Biophys J       Date:  2009-03-17       Impact factor: 1.733

5.  The polyprotein and FAR lipid binding proteins of nematodes: shape and monomer/dimer states in ligand-free and bound forms.

Authors:  Alexandra S Solovyova; Nicola Meenan; Lindsay McDermott; Antonio Garofalo; Jannette E Bradley; Malcolm W Kennedy; Olwyn Byron
Journal:  Eur Biophys J       Date:  2003-04-12       Impact factor: 1.733

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.